secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001493152-25-004428
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 31, 2025 for non-compliance with minimum bid price of $1.00 per share.
- Bid price below $1.00 for 30 consecutive business days triggered the notice.
- Has 180 calendar days (until July 30, 2025) to regain compliance.
- To cure, closing bid must be at least $1.00 for 10 consecutive business days.
- May consider reverse stock split; second 180-day period available if other standards met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315225004428/0001493152-25-004428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315225004428/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer